Sharika Enterpr. (540786)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive ROCE of 4.53% suggests some return is being generated at the capital-employed level despite negative ROE.
• Latest quarter sales of ₹16 Cr show the business still has an operating revenue base.
• Book value of ₹5.37 per share provides some tangible asset support, though modest.
• Small market cap of ₹139 Cr means meaningful operational improvements could move the needle if a genuine turnaround occurs.

Concerns

• Negative ROE of -3.83% and a latest-quarter net loss of ₹3 Cr indicate unprofitable operations.
• Sales growth of -27.31% and profit growth of -1128.57% reflect severe fundamental deterioration.
• P/B of 5.82 is expensive for a loss-making trader, especially with the stock at its 52-week high of ₹31.23.
• Piotroski F-Score of 3/9 signals weak financial health; no dividend is paid and promoter holding data is unavailable.

AI Analysis

Let me look at Sharika Enterpr. through the Graham lens: price is what you pay, value is what you get. At ₹31.23 with a market cap of ₹139 Cr, the stock is trading at 5.82 times book value of ₹5.37. That multiple is far too rich for a company that earned negative ROE of -3.83%. The latest quarter shows sales of ₹16 Cr but a net loss of ₹3 Cr. Meanwhile, sales growth is down 27.31% and profit growth has collapsed by 1128.57%. This is not a compounding machine; it looks like a business under stress. The trading and distribution industry rarely has a durable moat. With no pricing power and low barriers to entry, I need a strong balance sheet and clean numbers. The Piotroski F-Score is only 3/9, pointing to weak financial health. ROCE of 4.53% is positive but unimpressive. Dividend yield is zero, so I am not being paid to wait. Promoter holding is not available; I prefer owners who are visibly invested alongside me. Some will point to the 52-week range of ₹8.26 to ₹31.23 and see momentum. I see a stock priced for perfection at the top of its range while fundamentals are deteriorating. Without debt/equity data, I cannot assess leverage, which makes me even more cautious. Could this become a turnaround? Perhaps. But as value investors, we do not speculate on hope. We require a margin of safety. At ₹31.23, Sharika does not offer that. I would rather miss the recovery than risk permanent capital loss on a business whose numbers are going backward. No thank you.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer